Activity of two long-acting rifamycins, rifapentine and FCE 22807, in experimental murine tuberculosis

This publication has 10 references indexed in Scilit:

• High-performance liquid chromatographic determination of rifapentine and its metabolite in human plasma by direct injection into a shielded hydrophobic phase column
  Journal of Chromatography A, 1991
• In vitro activities against mycobacteria of two longacting rifamycins, FCE22807 and CGP40/469A (SPAS-565)
  Tubercle, 1990
• A Controlled Trial of 3-Month, 4-Month, and 6-Month Regimens of Chemotherapy for Sputum-smear-negative Pulmonary Tuberculosis: Results at 5 Years
  American Review of Respiratory Disease, 1989
• Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis: Final report
  Tubercle, 1986
• Laboratory evaluation of a new long-acting 3-azinomethylrifamycin FCE 22250.
  The Journal of Antibiotics, 1985
• Controlled trial of 4 three-times-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis second report: the results up to 24 months
  Tubercle, 1982
• Antibacterial activity of DL 473, a new semisynthetic rifamycin derivative.
  The Journal of Antibiotics, 1981
• Assay of rifampicin in serum
  Journal of Clinical Pathology, 1974
• A Selective Oleic Acid Albumin Agar Medium For Tubercle Bacilli
  Journal of Medical Microbiology, 1972
• COMBINED DRUG TREATMENT OF TUBERCULOSIS. III. CLINICAL APPLICATION OF THE PRINCIPLES OF APPROPRIATE AND ADEQUATE CHEMOTHERAPY TO THE TREATMENT OF PULMONARY TUBERCULOSIS
  Journal of Clinical Investigation, 1959